Scarica l'app Stockscreener
0.9882
4.06%
-0.0418
Dopo l'orario di chiusura:
1.07
0.0818
+8.28%
Precedente Chiudi:
$1.03
Aprire:
$1.018
Volume 24 ore:
8,516
Relative Volume:
0.02
Capitalizzazione di mercato:
$11.60M
Reddito:
$248.40K
Utile/perdita netta:
$-3.05M
Rapporto P/E:
-3.7848
EPS:
-0.2611
Flusso di cassa netto:
$-3.30M
1 W Prestazione:
-4.06%
1M Prestazione:
-6.77%
6M Prestazione:
-50.84%
1 anno Prestazione:
-55.74%
Intervallo 1D:
$0.9882
$1.018
Intervallo di 1 settimana:
$0.9882
$1.04
Portata 52W:
$0.7282
$3.68
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
Nome
Cytomed Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare GDTC vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
0.9882 | 11.60M | 248.40K | -3.05M | -3.30M | -0.2611 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Cytomed Therapeutics Ltd Borsa (GDTC) Ultime notizie
GDTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Rising R&D loss as CytoMed (NASDAQ: GDTC) advances γδ T cell therapies - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) flags losses and funding needs in 2025 report - Stock Titan
Stop Loss: Why is CytoMed Therapeutics Limited stock going upWeekly Trade Analysis & Community Consensus Trade Alerts - baoquankhu1.vn
AI Stocks: Can CytoMed Therapeutics Limited withstand a market correctionMarket Performance Recap & Scalable Portfolio Growth Ideas - baoquankhu1.vn
GDTC SEC FilingsCytoMed Therapeutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Interview with the Chairman: CytoMed Therapeutics Ltd. (NASDAQ:GDTC) - The Wall Street Transcript
GDTC Technical Analysis & ETF Price Forecast - Intellectia AI
GDTC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
GDTC Should I Buy - Intellectia AI
GDTCCytoMed Therapeutics Ltd Latest Stock News & Market Updates - Stock Titan
CytoMed Therapeutics (NASDAQ:GDTC) Trading Up 1% – Still a Buy? - Defense World
Insider Sell: What analysts say about CytoMed Therapeutics Limited stock2025 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
CytoMed Therapeutics And 2 More Penny Stocks With Promising Prospects - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress - Yahoo Finance
Published on: 2026-01-29 21:36:08 - baoquankhu1.vn
Cancer cell therapy company hits back at claims about its first human trial - Stock Titan
CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress - finance.yahoo.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CytoMed Therapeutics updates on cell therapy pipeline and trials By Investing.com - Investing.com Nigeria
CytoMed Therapeutics updates on cell therapy pipeline and trials - Investing.com
Biotech seeks investor views on share-based access to cell therapy - Stock Titan
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital - finance.yahoo.com
How buybacks impact CytoMed Therapeutics Limited stock valueExit Point & Risk Controlled Daily Plans - Улправда
Is CytoMed Therapeutics Limited stock attractive after correctionJuly 2025 Technicals & Expert-Curated Trade Recommendations - DonanımHaber
How CytoMed Therapeutics Limited (F98) stock performs in volatility spikes2025 Growth vs Value & Fast Entry and Exit Trade Plans - Улправда
Is CytoMed Therapeutics Limited stock a smart buy before Fed meeting2025 Valuation Update & Daily Profit Maximizing Trade Tips - Улправда
CytoMed Therapeutics (NASDAQ:GDTC) Trading Up 7.2% – Here’s Why - Defense World
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
CytoMed stock jumps after announcing clinical trial partnership in Malaysia By Investing.com - Investing.com South Africa
CytoMed stock jumps after announcing clinical trial partnership in Malaysia - Investing.com India
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital - Investing.com
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital By Investing.com - Investing.com South Africa
CytoMed Therapeutics (NASDAQ: GDTC) plans first-in-human gamma delta T cell trial in Malaysia - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) to run first-in-human Malaysia trial of donor-derived γδ T cells - Stock Titan
CytoMed Therapeutics (GDTC) Stock Analysis Report | Financials & Insights - Benzinga
Why CytoMed Therapeutics Limited (F98) stock appears on watchlists2025 Price Momentum & Reliable Trade Execution Plans - Newser
Will CytoMed Therapeutics Limited (F98) stock benefit from Fed rate cuts2025 Short Interest & Intraday High Probability Setup Alerts - Newser
CytoMed acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
CytoMed Therapeutics acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
Applying Wyckoff theory to CytoMed Therapeutics Limited stock2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
What earnings margins imply for CytoMed Therapeutics Limited (F98) stockQuarterly Trade Review & AI Driven Stock Movement Reports - newser.com
How CytoMed Therapeutics Limited stock reacts to job market dataPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
Can you recover from losses in CytoMed Therapeutics LimitedTrade Risk Report & AI Driven Stock Reports - newser.com
CytoMed Therapeutics Ltd (GDTC) can make a big difference with a little luck - Setenews
Will CytoMed Therapeutics Limited stock outperform Dow Jones indexJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Why CytoMed Therapeutics Limited stock remains a top recommendationWatch List & Safe Entry Point Identification - newser.com
CytoMed acquires TC BioPharm’s gamma delta T cell technology By Investing.com - Investing.com Canada
Cytomed Therapeutics Ltd Azioni (GDTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):